Tag: multiregional clinical trials

ICH Guidelines for Multiregional Clinical Trials: Understanding E5, E17, and Global Harmonization

Posted on digi By digi

ICH Guidelines for Multiregional Clinical Trials: Understanding E5, E17, and Global Harmonization Mastering Multiregional Clinical Trials with ICH E5 and E17 Guidelines Conducting clinical trials across multiple regions has become increasingly essential for pharmaceutical companies aiming for simultaneous global drug approvals. To address the complexity of such trials, the International Council for Harmonisation (ICH) introduced…

Read More “ICH Guidelines for Multiregional Clinical Trials: Understanding E5, E17, and Global Harmonization” »

ICH Guidelines, Regulatory Guidelines

Implementing ICH E5 and E17 Guidelines for Multiregional Clinical Trials

Posted on digi By digi

Implementing ICH E5 and E17 Guidelines for Multiregional Clinical Trials Applying ICH E5 and E17 to Global Multiregional Clinical Trials As clinical research increasingly spans continents, the need for harmonized trial practices becomes critical. Multiregional Clinical Trials (MRCTs) are a cornerstone of modern global drug development, enabling simultaneous data collection and submission across multiple regulatory…

Read More “Implementing ICH E5 and E17 Guidelines for Multiregional Clinical Trials” »

ICH Guidelines, Regulatory Guidelines